김열홍

    

  #위암#대장암#간담췌암

학력

1977 .03 ~ 1983 .02 : 고려대학교 의과대학, 학사
1985 .03 ~ 1987 .02 : 고려대학교 의과대학, 석사
1987 .03 ~ 1993 .02 : 고려대학교 의과대학, 박사
1993 .02 ~ 1995 .02 : M.D. Anderson Cancer Center Gastrointestinal Medical Oncology, Postdoctoral fellow
~ : M.D. Anderson Cancer Center Thoracic Medical Oncology Postdoctoral fellow

경력

1995 .03 ~ : 고려대학교 의과대학, 교수
2001 .04 ~ 2011 .03 : 보건복지부지정 폐암, 유방암/난소암 유전체연구센터, 소장
2005 .11 ~ 2016 .01 : 고려대학교 안암병원 암센터, 센터장
2007 .12 ~ : 고려대학교 안암병원 임상시험심사위원회, 위원 및 위원장
2010 .03 ~ 2012 .02 : 고려대학교 의과학연구지원센터, 안암연구지원소장
2011 .09 ~ 2017 .08 : 고려대학교 암 연구소, 소장
2014 .12 ~ 2018 .11 : 고려대학교 안암병원 임상시험센터, 센터장
2017 .06 ~ : 보건복지부지정 정밀의료사업단, 단장

2007 .01 ~ : 건강보험심사평가원 진료심사평가위원회, 비상근심사위원
2007 .12 ~ : 건강보험심사평가원 암질환심의위원회, 위원
2012 .04 ~ 2014 .03 : 식품의약품안전평가원 항암제 및 허가초과 의약품 평가분과, 자문위원
2012 .06 ~ 2014 .06 : 보건복지부 보건의료기술 정책심의위원회, 위원
2013 .03 ~ 2017 .03 : 한국연구재단 기초연구본부 의약학단, 전문위원
2018 .01 ~ : 건강보험심사평가원 임상연구급여평가위원회, 위원장

논문

[국외논문] (Female Chromosome X Mosaicism Is Age-Related and Preferentially Affects the Inactivated X Chromosome.)

[국외논문] (Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells.)
/ 2019.09.01

[국외논문] (Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer)
/ 2019.08.01

[국외논문] (A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01).)
/ 2019.01.01

[국외논문] (Isolation of spheroid-forming single cells from gastric cancer cell lines: enrichment of cancer stem-like cells.)
/ 2018.10.01

[SCI] (Helicobacter pylori and Prevention of gastric cancer.)
/ 2018.06.01

[국외논문] (Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study.)
/ 2018.01.01

[국외논문] (Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.)
/ 2017.10.01

[국내논문] (Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal. Malignancy: Recent Updates.)
/ 2017.07.01

[국외논문] (Association Between GWAS-identified Lung Adenocarcinoma Susceptibility Loci and EGFR Mutations in Never-Smoking Asian Women, and Comparison With Findings From Western Populations.)
/ 2017.01.01

[국외논문] (A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy)
/ 2012.03.01

[국외논문] (The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations)
/ 2012.03.01

[국외논문] (Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-kappa B and is associated with poor patient outcome)
/ 2012.01.01

[국외논문] (Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients)
/ 2012.01.01

[국외논문] (Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial)
/ 2012.01.01

[국외논문] (Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer)
/ 2011.10.01

[국외논문] (The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-kappa B activity and down-regulating Bfl-1)
/ 2011.08.01

[국외논문] (Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer)
/ 2011.03.01

[국외논문] (Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors)
/ 2011.01.01

[국외논문] (Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients)
/ 2010.12.01

[국외논문] (Selection of a Patient Subgroup with Advanced Esophageal Squamous Carcinoma Who Could Benefit from Second-Line Chemotherapy)
/ 2010.12.01

[국외논문] (Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma)
/ 2010.12.01

[국외논문] (Methylation of AKAP12 alpha Promoter in Lung Cancer)
/ 2010.11.01

[국외논문] (A Study of RET Proto-oncogene Polymorphisms in Association with Lung Cancer Risk in the Korean Population)
/ 2010.09.01

[국외논문] (Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea)
/ 2010.09.01

[국외논문] (A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma)
/ 2010.09.01

[국외논문] (The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia)
/ 2010.08.01

[국외논문] (High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer)
/ 2010.08.01

[국외논문] (Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer)
/ 2010.05.01

[국외논문] (Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients)
/ 2010.04.01

[국외논문] (Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients)
/ 2010.04.01

[국외논문] (The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease)
/ 2010.03.01

[국외논문] (Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial)
/ 2010.03.01

[국외논문] (A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer)
/ 2010.02.01

[국외논문] (Association of a progesterone receptor gene+331 G/A polymorphism with breast cancer risk: a meta-analysis)
/ 2010.01.01

[국외논문] (Association of a progesterone receptor gene+331 G/A polymorphism with breast cancer risk: a meta-analysis)
/ 2010.01.01

[국외논문] (DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC))
/ 2009.09.01

[국외논문] (Chemotherapy Related Oral and Gastrointestinal Mucositis)
/ 2009.09.01

[국외논문] (Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study)
/ 2009.07.01

[국외논문] (Array CGH Reveals Genomic Aberrations in Human Emphysema)
/ 2009.05.01

[국외논문] (Single-nucleotide polymorphisms in the promoter of the CDK5 gene and lung cancer risk in a Korean population)
/ 2009.05.01

[국외논문] (Microtubule-damaging Agents Enhance RASSF1A-induced Cell Death in Lung Cancer Cell Lines)
/ 2009.03.01

[국외논문] (Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis)
/ 2009.02.01

[국외논문] (Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer)
/ 2009.01.01

[국외논문] (Effect of BRCA1 Haplotype on Survival of Non-Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy)
/ 2008.12.01

[국외논문] (The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population)
/ 2008.12.01

[국외논문] (Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population)
/ 2008.11.01

[국외논문] (Primary Adrenal Lymphoma Presenting with Cauda Equina Syndrome)
/ 2008.11.01

[국외논문] (A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer)
/ 2008.10.01

[국외논문] (Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer)
/ 2008.09.01

[국외논문] (Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study)
/ 2008.06.01

[국외논문] (Association study of TP53 polymorphisms with lung cancer in a Korean population)
/ 2008.06.01

[국외논문] (PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo)
/ 2008.06.01

[국외논문] (Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NF kappa B and Bcl-X-L)
/ 2008.06.01

[국외논문] (The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer)
/ 2008.03.01

[국외논문] (Properties of the amniotic membrane may be applicable in cancer therapy)
/ 2008.02.01

[국외논문] (Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue)
/ 2007.11.01

[국외논문] (Reduced dose of imatinib for patients with chronic myeloid leukemia and low body surface area)
/ 2007.11.01

[국외논문] (Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro)
/ 2007.09.01

[국외논문] (Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population)
/ 2007.07.01

[국외논문] (Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial)
/ 2007.07.01

[국외논문] (A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer)
/ 2007.05.01

[국외논문] (Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity)
/ 2007.04.01

[국외논문] (Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer)
/ 2007.02.01

[국외논문] (Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung)
/ 2007.01.01

[국외논문] (Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer)
/ 2007.01.01

저서

유방학저자
일조각
1999

종양학저자
일조각
2012

보도자료

[쿠키가 만난 명의-김열홍 고대안암병원 종양혈액내과 교수] 대장암 환자 치료중엔 잘 먹는 것이 중요
http://news.kmib.co.kr/article/view.asp?arcid=0923687972&code=14130000&cp=nv

"항암제 접근성 강화 위해 위험분담 가능한 '선별급여' 필요"
http://www.docdocdoc.co.kr/news/articleView.html?idxno=1069123

[쿠키가 만난 명의] 대장암, 국내 발병률 세계 1위…현대화된 생활습관이 원인
http://www.kukinews.com/newsView/kuk201702050084

[人-MORE] "400억 지원으로 1조 드는 신약개발 가능한가?"
http://www.monews.co.kr/news/articleView.html?idxno=301694

1차 치료제가 전이성 대장암을 좌우한다‥'얼비툭스' 존재 이유
http://medipana.com/news/news_viewer.asp?NewsNum=257476&MainKind=A&NewsKind=5&vCount=12&vKind=1

포스팅

포스팅 내용이 없습니다.

영상자료

[Dr.log] 미래 암 치료 패러다임을 바꾸는 정밀의료
https://tv.naver.com/v/16302571

[공공기관홍보영상 아이엔씨미디어] [교육영상]대한의사협회_마약오남용 교육영상_김열홍교수님편
https://tv.naver.com/v/12968708

발표자료

발표자료 내용이 없습니다.